TARA BAKER: Open Payments
NPI 1023460839 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 25 payments from 8 companies in 2025. Trend: 2023 $886 · 2024 $937 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $162 |
| HEARTFLOW, INC. | 1 | $159 |
| Amgen Inc. | 2 | $139 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| Esperion Therapeutics, Inc. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Kestra Medical Technology Services, Inc. | 1 | $36 |
| Lilly USA, LLC | 1 | $17 |
Products named: ELIQUIS, FFRct, REPATHA, NEXLETOL, CAMZYOS, JARDIANCE, Assure WCD, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
